Logo

Strides Pharma Scien Share Price

Strides Pharma Scien (INR)647.15-11.8   (-1.8%)

Exchange ScripsBSE532531NSESTARISININE939A01011

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Strides Pharma Scien Performance

Market performance
Open price663.6
High668.95
Volumes276114
Prev Close647.15
Low638.6
Closing date2025-01-10
Historical performance
1 Year High1675.00
3 Year High1675.00
5 Year High1675.00
1 Year Low637.50
3 Year Low263.35
5 Year Low263.35

Strides Pharma Scien Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
5967
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
-84.22
Dividend Yield
Dividend Yield
0.04 %

Strides Pharma Scien Investment Returns

1 Year
-6.5%
3 Years
43.3%
5 Years
65.7%
10 Years
-30.2%

Strides Pharma Scien Technicals

IndicatorsValueSignal
5-DMA668.59Bearish
10-DMA675Bearish
20-DMA684.39Bearish
50-DMA1099.88Bearish
100-DMA1259.37Bearish
200-DMA1091.53Bearish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters1515151616
Foreign Investors---------------
Domestic Investors1515151616
Public Investors95994919028468091166101622
Government11111

Strides Pharma Scien Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income49813521334594
Operating Profit7830520511196863
Interest3144261117671501
Depreciation2207243323302063
Profit Before Tax-1169-2862-65252754
Consolidated Net Profit-706-2026-46022684
Adjusted EPS-8-22-5130

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital919903898897
Total Reserves20306210252267026823
Minority Interest-539-394241373
Total Non-Current Liabilities621412103965712644
Total Liabilities55724637346760768168
Capital Work in Progress7994835622276
Total Assets55724637346760768168

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities7011444-25784814
Cash Flow from Investing Activities-15023025-1187-5208
Cash Flow from Financing Activitie-6933-21394213-158
Net Cash Inflow / Outflow-14251330448-552
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of -84.22.
  • 3Y Stock Price CAGR of the stock is 12.3.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹7830 Million.
  • The company generated revenue of ₹40511 Million in the previous financial year.

Strides Pharma Scien

647.15-11.8   (-1.8%)

Investment Amount: ₹ 68415
Current Value: ₹ 64715
Performance: -5.4%
P/L: ₹ -3700
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
JAICORPLTD173(-10%)
AWL291.1(-10%)
SPANDANA405.8(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month